He said: “The UK is leading the way to develop a world-first vaccine for this vomiting bug, starting with this innovative ...

Vaccine maker Novavax (NASDAQ: NVAX) has had a rollercoaster of a year. In May, the company's shares soared after it ...

At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II dose-ranging trial for mRNA-1403, a vaccine ...

How bad is this news for Novavax? Let's find out. Image source: Getty Images.

The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.

First to Worst: Ranking Women’s College Basketball Newcomers- Hailey Van Lith, Raegan Beers and More The #1 fast food chain ...

FluMist, the nasal flu vaccine spray, was approved in September by the U.S. Food and Drug Administration for at-home use ...

Northwestern University sued vaccine maker Moderna, Inc. on Wednesday, October 16, in the U.S. District Court for the ...

The WHO said Friday it had for the first time prequalified a mpox vaccine -- a move expected to speed up access to the jabs ...

Building local capacity to manufacture drugs, vaccines, and health products is not enough. Officials must work to ensure ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

Researchers at the University of Sheffield have been awarded funding for their infectious disease technology that could make ...